Chi Sheng Pharma & Biotech Past Performance
How has Chi Sheng Pharma & Biotech performed over the past 5 years?
Past Performance Score4/6
Past Performance Score 4/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 4111 has a high level of non-cash earnings.
Growing Profit Margin: 4111's current net profit margins (9.8%) are higher than last year (4.3%).
Past Earnings Growth Analysis
Earnings Trend: 4111's earnings have grown by 1.5% per year over the past 5 years.
Accelerating Growth: 4111's earnings growth over the past year (162.4%) exceeds its 5-year average (1.5% per year).
Earnings vs Industry: 4111 earnings growth over the past year (162.4%) exceeded the Pharmaceuticals industry 20.8%.
Return on Equity
High ROE: 4111's Return on Equity (9.9%) is considered low.